1824. Deputy Ken O'Flynn asked the Minister for Health the number of nurses, doctors, and health and social care professionals recruited internationally by the HSE in each year from 2020 to 2026, broken down by profession and country of origin. [41691/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
27,342 questions match, newest first.
1825. Deputy Ken O'Flynn asked the Minister for Health the estimated annual attrition rate within the HSE workforce for nurses, doctors, and health and social care professionals in each year from 2020 to 2026. [41692/26]
1826. Deputy Ken O'Flynn asked the Minister for Health the number of Irish-trained healthcare professionals who emigrated or took up employment outside the State in each year since 2020, insofar as figures are available. [41693/26]
1827. Deputy Ken O'Flynn asked the Minister for Health the total annual expenditure incurred by the HSE on international recruitment campaigns, relocation packages, recruitment agencies, and associated supports from 2020 to 2026. [41694/26]
1828. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has conducted any assessment of long-term workforce sustainability should international recruitment levels decline. [41695/26]
1829. Deputy Ken O'Flynn asked the Minister for Health the current vacancy rate across nursing, medical and health and social care professional grades by Health Region. [41696/26]
1830. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has set any targets to reduce reliance on international recruitment over the next five years. [41697/26]
1831. Deputy Ken O'Flynn asked the Minister for Health whether any national guidance exists governing how referrals deemed ineligible for SCAN services are recorded, categorised, or redirected within the mental health system. [41698/26]
1832. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any mechanism to track outcomes for persons referred to SCAN services but redirected to alternative pathways. [41699/26]
1833. Deputy Ken O'Flynn asked the Minister for Health whether any assessment has been undertaken regarding regional variation in SCAN eligibility decisions or referral acceptance practices. [41700/26]
1834. Deputy Ken O'Flynn asked the Minister for Health whether the forthcoming SCAN KPI framework will include data relating to rejected, redirected, or ineligible referrals. [41701/26]
1835. Deputy Ken O'Flynn asked the Minister for Health whether consideration is being given to establishing a nationally standardised dataset for referrals not accepted into SCAN services. [41702/26]
1836. Deputy Ken O'Flynn asked the Minister for Health whether any adverse incident review process exists where a person deemed ineligible for SCAN services subsequently presents in crisis, self-harms, or requires emergency intervention. [41703/26]
1837. Deputy Ken O'Flynn asked the Minister for Health whether SCAN services currently operate under nationally standardised eligibility criteria and whether these criteria are publicly available. [41704/26]
1838. Deputy Ken O'Flynn asked the Minister for Health whether any audit has been undertaken into onward referral pathways for persons not accepted into SCAN services. [41705/26]
1839. Deputy Ken O'Flynn asked the Minister for Health whether the Department or HSE has undertaken any modelling of the projected annual eligible population for reimbursement of tirzepatide or semaglutide for obesity treatment over the next five years. [41712/26]
1840. Deputy Ken O'Flynn asked the Minister for Health whether any estimate has been produced of the potential annual Exchequer cost associated with reimbursement of obesity pharmacotherapies under current licensing criteria. [41713/26]
1841. Deputy Ken O'Flynn asked the Minister for Health whether any national eligibility framework, prioritisation framework, or phased access model is under development for obesity pharmacotherapy reimbursement. [41714/26]
1842. Deputy Ken O'Flynn asked the Minister for Health whether multidisciplinary assessment, psychological screening, or behavioural intervention participation will be mandatory prior to reimbursement approval for obesity pharmacotherapies. [41715/26]
1843. Deputy Ken O'Flynn asked the Minister for Health whether any assessment has been undertaken of the long-term fiscal sustainability of reimbursing GLP-1 and dual agonist obesity therapies within the public health system. [41716/26]
1844. Deputy Ken O'Flynn asked the Minister for Health whether any formal safeguards or governance framework are being developed in relation to proposed reimbursement pathways for obesity pharmacotherapies in adolescent patients. [41717/26]
1845. Deputy Ken O'Flynn asked the Minister for Health whether any estimate has been produced of the projected number of adolescent patients who could potentially meet the proposed reimbursement criteria for semaglutide. [41718/26]
1846. Deputy Michael Cahill asked the Minister for Health if she will urgently meet with a professional oversight body (details supplied); and if she will make a statement on the matter. [41724/26]
1847. Deputy Seán Crowe asked the Minister for Health the number of WTEs in children’s respite services in the CHO7 area each year for the past five years, in tabular form. [41732/26]
1848. Deputy Seán Crowe asked the Minister for Health the number of properties that are in use for the provision of children’s respite services in the CHO7 area each year for the past five years, in tabular form. [41733/26]